Open AccessEfficacy of Shexiang Baoxin Pills for the treatment of unstable angina pectoris
Author(s) -
Huadong Chen,
Qianqian Dong,
Xiang Zheng
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000017119
Subject(s) - medicine , funnel plot , meta analysis , cochrane library , pill , publication bias , medline , unstable angina , subgroup analysis , angina , database , pharmacology , coronary heart disease , myocardial infarction , political science , computer science , law
Background: Shexiang Baoxin Pills (SBP) is widely used for the treatment of unstable angina pectoris (UAP) in China. However, the clinical evidence on the efficacy of SBP for the treatment of UAP is not well concluded. Methods: Seven electronic databases will be searched for eligible studies: MEDLINE, EMBASE, The Cochrane Library, Wanfang database, Chinese National Knowledge Infrastructure database, VIP database, and Chinese Biological and Medicine database. Data of included studies will be extracted, and quality will be evaluated. Data synthesis will be performed using RevMan software. Subgroup analysis and sensitivity analysis will also be carried out. Publication bias will be evaluated using funnel plot if included studies are sufficient. Results: This systemic review and meta-analysis will provide synthesized result of clinical efficacy of SBP for the treatment of UAP. Conclusions: This systemic review and meta-analysis will provide high-quality evidence on the clinical efficacy of SBP for the treatment of UAP. Registration: PEROSPERO CRD42019124668